AssetMark Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
|
|||||
|
2025
Q1 | $2.1M | Sell |
|
|||||
|
2024
Q4 | $2.72M | Buy |
|
|||||
|
2024
Q3 | $2.11M | Buy |
|
|||||
|
2024
Q2 | $2.28M | Buy |
|
|||||
|
2024
Q1 | $1.67M | Sell |
|
|||||
|
2023
Q4 | $4.87M | Buy |
|
|||||
|
2023
Q3 | $3.18M | Buy |
|
|||||
|
2023
Q2 | $2.26M | Buy |
|
|||||
|
2023
Q1 | $2M | Buy |
|
|||||
|
2022
Q4 | $2.13M | Buy |
|
|||||
|
2022
Q3 | $1.74M | Buy |
|
|||||
|
2022
Q2 | $1.31M | Buy |
|
|||||
|
2022
Q1 | $858K | Buy |
|
|||||
|
2021
Q4 | $431K | Buy |
|
|||||
|
2021
Q3 | $142K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1K | Buy |
|
|||||
|
2019
Q1 | $1K | Sell |
|
|||||
|
2018
Q4 | $2K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2K | Buy |
|
|||||
|
2017
Q3 | $0 | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1K | Buy |
|